About Nebula Genomics
Nebula Genomics is a company based in San Francisco (United States) founded in 2016 by George M Church was acquired by ProPhase Labs in August 2021. It operates as a Direct-to-Consumer (D2C) and Subscription Services. Nebula Genomics has raised $4.3 million across 1 funding round from investors including Khosla Ventures, Arch Venture Partners and ProPhase Labs. The company has 2 employees as of December 31, 2024. Nebula Genomics offers products and services including 30x Whole Genome Sequencing and 100x Whole Genome Sequencing. Nebula Genomics operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Depixus and Seven Bridges Genomics, among others.
- Headquarter San Francisco, United States
- Employees 2 as on 31 Dec, 2024
- Founders George M Church
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nebula Genomics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.3 M (USD)
in 1 rounds
-
Latest Funding Round
$4.3 M (USD), Seed
Aug 29, 2018
-
Investors
Khosla Ventures
& 11 more
-
Employee Count
2
as on Dec 31, 2024
-
Acquired by
ProPhase Labs
(Aug 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nebula Genomics
Nebula Genomics offers a comprehensive portfolio of products and services, including 30x Whole Genome Sequencing and 100x Whole Genome Sequencing.
Entire genome is sequenced at 30x coverage depth.
Entire genome is sequenced at 100x coverage depth.
People of Nebula Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Nebula Genomics
Nebula Genomics has successfully raised a total of $4.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.3 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nebula Genomics
Nebula Genomics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Arch Venture Partners and ProPhase Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Early-stage venture capital firm investing in the US and UK
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked |
Investor details for Nebula Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nebula Genomics
Investment portfolio details for Nebula Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nebula Genomics
Detailed financials for Nebula Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nebula Genomics Comparisons
Peer comparison for Nebula Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nebula Genomics
Nebula Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Depixus and Seven Bridges Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
Detailed competitors of Nebula Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nebula Genomics
Complete news archive for Nebula Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nebula Genomics
Nebula Genomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Nebula Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nebula Genomics is a funded company, having raised a total of $4.3M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Nebula Genomics is 2.
Whole genome sequencing is offered by Nebula Genomics to decode 100 of DNA for health and ancestry insights. Services are focused on personal genomics, covering sectors like healthcare and biotechnology. Advanced DNA testing solutions, including 30x and 100x coverage, are provided for comprehensive genetic analysis. Privacy protection technology is integrated to secure genomic data. Partnerships with academic and research institutions are maintained to enhance genomic research applications.
Nebula Genomics's top competitors include Helix, Benchling and BioAge Labs.
Nebula Genomics offers 30x Whole Genome Sequencing and 100x Whole Genome Sequencing.
Nebula Genomics has 12 investors. Key investors include Khosla Ventures, Arch Venture Partners, ProPhase Labs, Heartbeat Labs, and Fenbushi Capital.